Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Embecta Corp.

EMBC · Nasdaq · CIK 0001872789 · Healthcare · Medical Instruments & Supplies

INSIDER SIGNAL

68.3 / 100

4 buyers · 4 purchase transaction lines · $557.9K gross purchase

WHY THIS SIGNAL?

Buyer breadthStrong
Purchase sizeModerate
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+28.0 / 35
Purchase size+14.7 / 25
Role+13.0 / 20
Recency+3.3 / 10
Conviction+9.3 / 10

What is holding the score back?

  • ⚠ Role scores low · most senior buyer: President and CEO (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Morris Milton MayoDirector
▼
Roth Anthony M.VP, Chief Accounting Officer
○
Kurdikar DevdattPresident and CEO
●
Elguicze JacobSVP and CFO
●
Mann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLO
●
HOMBACH ROBERT J.Director
●
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS4
PURCHASE CONCENTRATION40%Largest buyer: HOMBACH ROBERT J. · $223.7K
CLUSTER BUYING · 15D4 insidersPeak activity: 2026-08-12–2026-08-12

Roles in the peak window: Director, Pres, Pharm Svc&Prod Mgmt, CLO, President and CEO, SVP and CFO. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

68.3 / 100

Latest recorded score

↓ -0.2 ptsversus the previous recorded snapshot
  1. 68.8
  2. 68.7
  3. 68.6
  4. 68.5
  5. 68.3

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

4Purchases
1Sales
24Other Form 4 lines
19SEC filings · 365 days
BUYING4 qualifying P line(s) · 180 days
SELLING1 sale line(s) · context only
OTHER2 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+16.3%
3M
+77.1%
6M
-35.8%
12M
-58.9%

Volatility & liquidity

Volatility
72.5%
Beta
—
Avg daily value
USD 7.7M

Valuation

Market cap
USD 322.1M
P/E
3.4×

Fundamentals

Profit margin
8.8%
ROE
—
Industry
Medical Instruments & Supplies

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, P/E, Profit margin · Fiscal year ended: 2025-09-30 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
5,825,802
Previous report
5,547,979
Avg daily volume
1,073,095
Days to cover
5.4

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-12Mann Jeffrey ZPurchase (P)Common Stock20,000USD 4.99USD 99,800SEC filing ↗
2026-08-12Kurdikar DevdattPurchase (P)Common Stock30,000USD 4.70USD 141,000SEC filing ↗
2026-08-12HOMBACH ROBERT J.Purchase (P)Common Stock45,000USD 4.97USD 223,650SEC filing ↗
2026-08-12Elguicze JacobPurchase (P)Common Stock20,000USD 4.67USD 93,400SEC filing ↗
2025-05-23Melcher David FPurchase (P)Common Stock10,000USD 10.60USD 106,000SEC filing ↗
2025-02-25Melcher David FPurchase (P)Common Stock13,000USD 13.67USD 177,710SEC filing ↗
2024-02-12Melcher David FPurchase (P)Common Stock2,000USD 16.25USD 32,500SEC filing ↗
2023-09-08Melcher David FPurchase (P)Common Stock6,233USD 15.77USD 98,294SEC filing ↗
2023-08-10Mann Jeffrey ZPurchase (P)Common Stock4,700USD 21.67USD 101,849SEC filing ↗
2023-08-10Kurdikar DevdattPurchase (P)Common Stock5,000USD 21.81USD 109,050SEC filing ↗
2023-08-10Elguicze JacobPurchase (P)Common Stock4,625USD 21.66USD 100,178SEC filing ↗
2023-02-15Melcher David FPurchase (P)Common Stock3,100USD 32.93USD 102,083SEC filing ↗
2023-02-15Melcher David FPurchase (P)Common Stock3,100USD 32.51USD 100,781SEC filing ↗

Form 4 evidence

29 transaction lines in the latest 365-day window; 136 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-04Morris Milton MayoSale (S)Common Stock6,293USD 5.88USD 37,003SEC filing ↗
2026-08-12Mann Jeffrey ZPurchase (P)Common Stock20,000USD 4.99USD 99,800SEC filing ↗
2026-08-12Kurdikar DevdattPurchase (P)Common Stock30,000USD 4.70USD 141,000SEC filing ↗
Show recent Form 4 evidence (25 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-04Morris Milton MayoSale (S)Common Stock6,293USD 5.88USD 37,003SEC filing ↗
2026-08-12Mann Jeffrey ZPurchase (P)Common Stock20,000USD 4.99USD 99,800SEC filing ↗
2026-08-12Kurdikar DevdattPurchase (P)Common Stock30,000USD 4.70USD 141,000SEC filing ↗
2026-08-12HOMBACH ROBERT J.Purchase (P)Common Stock45,000USD 4.97USD 223,650SEC filing ↗
2026-08-12Elguicze JacobPurchase (P)Common Stock20,000USD 4.67USD 93,400SEC filing ↗
2026-08-09Casner JeanTax withholding (F)Common Stock1,480USD 4.42USD 6,542SEC filing ↗
2026-06-01Roth Anthony M.Award / grant (A)Common Stock30,000USD 0.00USD 0SEC filing ↗
2026-02-11Reidy Christopher RAward / grant (A)Common Stock22,841USD 0.00USD 0SEC filing ↗
2026-02-11Prange KarenAward / grant (A)Common Stock22,841USD 0.00USD 0SEC filing ↗
2026-02-11Pomeroy ClaireAward / grant (A)Common Stock22,841USD 0.00USD 0SEC filing ↗
2026-02-11Morris Milton MayoAward / grant (A)Common Stock22,841USD 0.00USD 0SEC filing ↗
2026-02-11HOMBACH ROBERT J.Award / grant (A)Common Stock22,841USD 0.00USD 0SEC filing ↗
2026-02-11Anderson Carrie LAward / grant (A)Common Stock22,841USD 0.00USD 0SEC filing ↗
2025-11-26Roth Anthony M.Tax withholding (F)Common Stock1,881USD 12.57USD 23,644SEC filing ↗
2025-11-26Roth Anthony M.Award / grant (A)Common Stock32,817USD 0.00USD 0SEC filing ↗
2025-11-26Mann Jeffrey ZTax withholding (F)Common Stock19,605USD 12.57USD 246,435SEC filing ↗
2025-11-26Mann Jeffrey ZAward / grant (A)Common Stock104,050USD 0.00USD 0SEC filing ↗
2025-11-26Kurdikar DevdattTax withholding (F)Common Stock128,630USD 12.57USD 1,616,879SEC filing ↗
2025-11-26Kurdikar DevdattAward / grant (A)Common Stock392,012USD 0.00USD 0SEC filing ↗
2025-11-26Elguicze JacobTax withholding (F)Common Stock24,782USD 12.57USD 311,510SEC filing ↗
2025-11-26Elguicze JacobAward / grant (A)Common Stock125,613USD 0.00USD 0SEC filing ↗
2025-11-26Curtis ShaunTax withholding (F)Common Stock15,380USD 12.57USD 193,327SEC filing ↗
2025-11-26Curtis ShaunAward / grant (A)Common Stock49,094USD 0.00USD 0SEC filing ↗
2025-11-26Casner JeanTax withholding (F)Common Stock3,325USD 12.57USD 41,795SEC filing ↗
2025-11-26Casner JeanAward / grant (A)Common Stock38,783USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerEMBC
CIK0001872789
SectorHealthcare
IndustryMedical Instruments & Supplies Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history136 transaction lines from 2022-04-01 to 2026-09-04
13 P purchase lines · 2 S sale lines · 121 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.